OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
000576$8.5058

Guangdong Ganhua Science & Industry Co Ltd

Aerospace & DefenseVerified

Guangdong Ganhua Science & Industry Co Ltd has a market price of 8.5 CNY and a market cap of 3,709,554,819 CNY, with a price-to-earnings ratio of 48.97 and a price-to-book ratio of 2.25. The company's liquidity is characterized by a current ratio of 2.97 and a free cash flow of 95,195,780 CNY, indicating a moderate level of liquidity. The company's capital structure is supported by total assets of 2,324,347,380 CNY and total liabilities of 675,340,300 CNY, with a debt-to-equity ratio of 0.18. In terms of profitability, the company has a return on equity of 4.59% and a return on assets of 3.26%, which are below the industry median for Aerospace & Defense companies. The company's operating income of 110,238,720 CNY and net income of 75,757,890 CNY reflect its operational performance. The gross profit of 226,200,500 CNY indicates the company's ability to generate profit from its core operations. The company's revenue is concentrated in the aerospace and defense sectors, with no significant diversification into other markets. The company's geographic exposure is primarily within China, with no disclosed international operations. The company's growth trajectory is reflected in its revenue of 505,468,320 CNY and a capital expenditure of -11,122,470 CNY, indicating a slight reduction in capital spending. The company's outlook for the current fiscal year is positive, with a mean recommendation of 1.00 from analysts, indicating a strong buy. The company faces a medium level of liquidity risk, with a key flag indicating that net cash is negative after subtracting total debt. The dilution risk is low, with no significant dilution potential reported. The company's risk assessment indicates that it is not currently facing high dilution pressure. Recent events and filings have not indicated any significant changes in the company's operations or financial status. The company's recent earnings per share (EPS) of 0.17 CNY are below the mean EPS estimate of 0.36 CNY, suggesting a potential for improvement in earnings performance.

30-day price · 000576-0.66 (-7.2%)
Low$8.41High$9.95Close$8.50As of15 May, 00:00 UTC
Profile
CompanyGuangdong Ganhua Science & Industry Co Ltd
Ticker000576.SZ
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryAerospace & Defense
AI analysis

Business. Guangdong Ganhua Science & Industry Co Ltd is an aerospace and defense company that generates revenue primarily through the production and sale of industrial goods related to the aerospace and defense sectors.

Classification. The company is classified under the Industrials economic sector, Industrial Goods business sector, and Aerospace & Defense industry with a confidence level of 0.92.

Guangdong Ganhua Science & Industry Co Ltd has a market price of 8.5 CNY and a market cap of 3,709,554,819 CNY, with a price-to-earnings ratio of 48.97 and a price-to-book ratio of 2.25. The company's liquidity is characterized by a current ratio of 2.97 and a free cash flow of 95,195,780 CNY, indicating a moderate level of liquidity. The company's capital structure is supported by total assets of 2,324,347,380 CNY and total liabilities of 675,340,300 CNY, with a debt-to-equity ratio of 0.18. In terms of profitability, the company has a return on equity of 4.59% and a return on assets of 3.26%, which are below the industry median for Aerospace & Defense companies. The company's operating income of 110,238,720 CNY and net income of 75,757,890 CNY reflect its operational performance. The gross profit of 226,200,500 CNY indicates the company's ability to generate profit from its core operations. The company's revenue is concentrated in the aerospace and defense sectors, with no significant diversification into other markets. The company's geographic exposure is primarily within China, with no disclosed international operations. The company's growth trajectory is reflected in its revenue of 505,468,320 CNY and a capital expenditure of -11,122,470 CNY, indicating a slight reduction in capital spending. The company's outlook for the current fiscal year is positive, with a mean recommendation of 1.00 from analysts, indicating a strong buy. The company faces a medium level of liquidity risk, with a key flag indicating that net cash is negative after subtracting total debt. The dilution risk is low, with no significant dilution potential reported. The company's risk assessment indicates that it is not currently facing high dilution pressure. Recent events and filings have not indicated any significant changes in the company's operations or financial status. The company's recent earnings per share (EPS) of 0.17 CNY are below the mean EPS estimate of 0.36 CNY, suggesting a potential for improvement in earnings performance.
Key takeaways
  • Guangdong Ganhua Science & Industry Co Ltd is a company in the aerospace and defense industry with a market cap of 3,709,554,819 CNY.
  • The company has a price-to-earnings ratio of 48.97 and a price-to-book ratio of 2.25, indicating a moderate valuation.
  • The company's return on equity of 4.59% and return on assets of 3.26% are below the industry median for Aerospace & Defense companies.
  • The company's liquidity is characterized by a current ratio of 2.97 and a free cash flow of 95,195,780 CNY.
  • The company faces a medium level of liquidity risk, with a key flag indicating that net cash is negative after subtracting total debt.
  • The company's growth trajectory is reflected in its revenue of 505,468,320 CNY and a capital expenditure of -11,122,470 CNY.
  • # RATIONALES
  • margin_outlook_rationale: The company's gross profit margin is expected to remain stable due to consistent demand in the aerospace and defense sectors.
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$505.5M
Gross profit$226.2M
Operating income$110.2M
Net income$75.8M
R&D
SG&A
D&A
SBC
Operating cash flow$79.6M
CapEx-$11.1M
Free cash flow$95.2M
Total assets$2.32B
Total liabilities$675.3M
Total equity$1.65B
Cash & equivalents$70.0M
Long-term debt$288.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$505.5M$110.2M$75.8M$95.2M
FY-1$396.3M$16.8M$20.5M$24.2M
FY-2$323.3M-$261.4M-$233.1M-$247.2M
FY-3$445.4M$112.9M$119.4M$103.5M
FY-4$539.6M$49.9M$31.9M-$52.2M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$2.32B$1.65B$70.0M
FY-1$1.84B$1.61B
FY-2$1.84B$1.61B
FY-3$2.02B$1.76B
FY-4$1.85B$1.62B
PeriodOCFCapExFCFSBC
FY0$79.6M-$11.1M$95.2M
FY-1-$55.8M-$12.3M$24.2M
FY-2$42.6M-$23.2M-$247.2M
FY-3-$53.1M-$30.6M$103.5M
FY-4$120.4M-$17.1M-$52.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$169.5M$3.4M$1.9M
FQ-1$144.3M$37.2M-$1.8M
FQ-2$124.9M$56.3M$43.7M
FQ-3$139.9M$7.1M$26.5M
FQ-4$96.3M$10.2M$7.3M
FQ-5$117.9M$2.7M$486.2k
FQ-6$79.3M-$9.3M-$6.3M
FQ-7$121.2M$10.9M$12.5M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$2.40B$1.65B$138.5M
FQ-1$2.32B$1.65B$70.0M
FQ-2$2.26B$1.65B$129.2M
FQ-3$1.87B$1.62B$90.0M
FQ-4$1.84B$1.62B$146.9M
FQ-5$1.84B$1.61B
FQ-6$1.85B$1.61B$237.2M
FQ-7$1.87B$1.63B
PeriodOCFCapExFCFSBC
FQ0-$96.0M-$1.0M
FQ-1$79.6M-$11.1M
FQ-2$11.4M-$5.1M
FQ-3$31.8M-$4.0M
FQ-4$31.6M-$2.7M
FQ-5-$55.8M-$12.3M
FQ-6-$47.9M-$10.6M
FQ-7-$17.8M-$6.1M
Valuation
Market price$8.50
Market cap$3.71B
Enterprise value$3.93B
P/E49.0
Reported non-GAAP P/E
EV/Revenue7.8
EV/Op income35.6
EV/OCF49.4
P/B2.2
P/Tangible book2.2
Tangible book$1.65B
Net cash-$218.8M
Current ratio3.0
Debt/Equity0.2
ROA3.3%
ROE4.6%
Cash conversion1.1%
CapEx/Revenue-2.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Aerospace & Defense · cohort 6 companies
Metric000576Activity
Op margin21.8%4.8% medp25 0.2% · p75 11.7%top quartile
Net margin15.0%2.5% medp25 -1.2% · p75 9.3%top quartile
Gross margin44.8%16.0% medp25 5.1% · p75 29.5%top quartile
R&D / revenue2.7% medp25 0.4% · p75 4.0%
CapEx / revenue-2.2%3.3% medp25 2.7% · p75 3.8%bottom quartile
Debt / equity18.0%53.2% medp25 37.6% · p75 76.6%bottom quartile
Observations
IR observations
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.36 CNY
Last actual EPS0.17 CNY
Mean revenue estimate678,000,000 CNY
Last actual revenue505,468,320 CNY
Mean EBIT estimate171,000,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 02:53 UTCJob: 3c028926